Prospective comparison of longitudinal change in hepatic proton density fat fraction (PDFF) estimated by magnitude-based MRI (MRI-M) and complex-based MRI (MRI-C) (original) (raw)

Abstract

Purpose To compare longitudinal hepatic proton density fat fraction (PDFF) changes estimated by magnitude-vs. complexbased chemical-shift-encoded MRI during a weight loss surgery (WLS) program in severely obese adults with biopsy-proven nonalcoholic fatty liver disease (NAFLD). Methods This was a secondary analysis of a prospective dual-center longitudinal study of 54 adults (44 women; mean age 52 years; range 27-70 years) with obesity, biopsy-proven NAFLD, and baseline PDFF ≥ 5%, enrolled in a WLS program. PDFF was estimated by confounder-corrected chemical-shift-encoded MRI using magnitude (MRI-M)-and complex (MRI-C)-based techniques at baseline (visit 1), after a 2-to 4-week very low-calorie diet (visit 2), and at 1, 3, and 6 months (visits 3 to 5) after surgery. At each visit, PDFF values estimated by MRI-M and MRI-C were compared by a paired t test. Rates of PDFF change estimated by MRI-M and MRI-C for visits 1 to 3, and for visits 3 to 5 were assessed by Bland-Altman analysis and intraclass correlation coefficients (ICCs). Results MRI-M PDFF estimates were lower by 0.5-0.7% compared with those of MRI-C at all visits (p < 0.001). There was high agreement and no difference between PDFF change rates estimated by MRI-M vs. MRI-C for visits 1 to 3 (ICC 0.983, 95% CI 0.971, 0.99; bias = − 0.13%, p = 0.22), or visits 3 to 5 (ICC 0.956, 95% CI 0.919-0.977%; bias = 0.03%, p = 0.36). Conclusion Although MRI-M underestimates PDFF compared with MRI-C cross-sectionally, this bias is consistent and MRI-M and MRI-C agree in estimating the rate of hepatic PDFF change longitudinally.

Loading...

Loading Preview

Sorry, preview is currently unavailable. You can download the paper by clicking the button above.

References (40)

  1. Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized MR based biomarker of tissue fat concentration. J Magn Reson Imaging 36:1011-1014
  2. Reeder SB, Sirlin CB (2010) Quantification of liver fat with mag- netic resonance imaging. Magn Reson Imaging Clin N Am 18:337- 357
  3. Hernando D, Liang ZP, Kellman P (2010) Chemical shift-based water/fat separation: a comparison of signal models. Magn Reson Med 64:811-822
  4. Zand KA, Shah A, Heba E et al (2015) Accuracy of multiecho magnitude-based MRI [M-MRI] for estimation of hepatic proton density fat fraction [PDFF] in children. J Magn Reson Imaging 42: 1223-1232
  5. Kuhn JP, Hernando D, Mensel B et al (2014) Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis. J Magn Reson Imaging 39:1494-1501
  6. Bashir MR, Zhong X, Nickel MD et al (2015) Quantification of hepatic steatosis with a multistep adaptive fitting MRI approach: prospective validation against MR spectroscopy. AJR Am J Roentgenol 204:297-306
  7. Zhong X, Nickel MD, Kannengiesser SA, Dale BM, Kiefer B, Bashir MR (2014) Liver fat quantification using a multi-step adap- tive fitting approach with multi-echo GRE imaging. Magn Reson Med 72:1353-1365
  8. Yu H, Shimakawa A, Hines CD et al (2011) Combination of complex-based and magnitude-based multiecho water-fat separa- tion for accurate quantification of fat-fraction. Magn Reson Med 66:199-206
  9. Johnson BL, Schroeder ME, Wolfson T et al (2014) Effect of flip angle on the accuracy and repeatability of hepatic proton density fat fraction estimation by complex data-based, T1-independent, T2*- corrected, spectrum-modeled MRI. J Magn Reson Imaging 39: 440-447
  10. Hines CD, Frydrychowicz A, Hamilton G et al (2011) T[1] inde- pendent, T[2][*] corrected chemical shift based fat-water separation with multi-peak fat spectral modeling is an accurate and precise estimate of hepatic steatosis. J Magn Reson Imaging 33:873-881
  11. Tyagi A, Yeganeh O, Levin Y et al (2015) Intra-and inter- examination repeatability of magnetic resonance spectroscopy, magnitude-based MRI, and complex-based MRI for estimation of hepatic proton density fat fraction in overweight and obese children and adults. Abdom Imaging 40:3070-3077
  12. Xu L, Duanmu Y, Blake GM, Zhang C et al (2018) Validation of goose liver fat measurement by QCT and CSE-MRI with biochemical extraction and pathology as reference. Eur Radiol 28: 2003-2012
  13. Hoy AM, McDonald N, Lennen RJ et al (2018) Non-invasive as- sessment of liver disease in rats using multiparametric magnetic resonance imaging: a feasibility study. Biol Open 7. https://doi. org/10.1242/bio.033910
  14. Bannas P, Kramer H, Hernando D et al (2015) Quantitative mag- netic resonance imaging of hepatic steatosis: validation in ex vivo human livers. Hepatology 62:1444-1455
  15. Permutt Z, Le TA, Peterson MR et al (2012) Correlation between liver histology and novel magnetic resonance imaging in adult pa- tients with non-alcoholic fatty liver disease -MRI accurately quan- tifies hepatic steatosis in NAFLD. Aliment Pharmacol Ther 36:22- 29
  16. Tang A, Desai A, Hamilton G et al (2015) Accuracy of MR imaging-estimated proton density fat fraction for classification of dichotomized histologic steatosis grades in nonalcoholic fatty liver disease. Radiology 274:416-425
  17. Kuhn JP, Hernando D, Munoz del Rio A et al (2012) Effect of multipeak spectral modeling of fat for liver iron and fat quantifica- tion: correlation of biopsy with MR imaging results. Radiology 265:133-142
  18. Middleton MS, Heba ER, Hooker CA et al (2017) Agreement be- tween magnetic resonance imaging proton density fat fraction mea- surements and pathologist-assigned steatosis grades of liver biop- sies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753-761
  19. Middleton MS, Van Natta ML, Heba ER et al (2018) Diagnostic accuracy of magnetic resonance imaging hepatic proton density fat fraction in pediatric nonalcoholic fatty liver disease. Hepatology 67: 858-872
  20. Loomba R, Sirlin CB, Ang B et al (2015) Ezetimibe for the treat- ment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a ran- domized trial [MOZART trial]. Hepatology 61:1239-1250
  21. Le TA, Chen J, Changchien C et al (2012) Effect of colesevelam on liver fat quantified by magnetic resonance in nonalcoholic steatohepatitis: a randomized controlled trial. Hepatology 56:922- 932
  22. Noureddin M, Lam J, Peterson MR et al (2013) Utility of magnetic resonance imaging versus histology for quantifying changes in liver fat in nonalcoholic fatty liver disease trials. Hepatology 58:1930- 1940
  23. Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686-690
  24. Cui J, Philo L, Nyugen P et al (2016) Sitagliptin vs. placebo for non-alcoholic fatty liver disease: a randomized controlled trial. J Hepatol 65:369-376
  25. Ajmera VH, Cachey E, Ramers C et al (2019) MRI assessment of treatment response in HIV-associated NAFLD: a randomized trial of a Stearoyl-coenzyme-A-desaturase-1 inhibitor (ARRIVE trial). Hepatology 70:1531-1545
  26. Haufe WM, Wolfson T, Hooker CA et al (2017) Accuracy of PDFF estimation by magnitude-based and complex-based MRI in chil- dren with MR spectroscopy as a reference. J Magn Reson Imaging 46:1641-1647
  27. Fazeli SD, Fowler KJ, Mamidipalli A et al (2019) Hepatic steatosis and reduction in steatosis following bariatric weight loss surgery differs between segments and lobes. Eur Radiol 29:2474-2480
  28. Pooler BD, Wiens CN, MsMillan A et al (2019) Monitoring fatty liver disease with MRI following bariatric surgery: a prospective dual-center study. Radiology 290:682-690
  29. Yokoo T, Serai SD, Pirasteh A et al (2018) Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 286:486-498
  30. Yokoo T, Shiehmorteza M, Hamilton G et al (2011) Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T. Radiology 258:749-759
  31. Yokoo T, Bydder M, Hamilton G et al (2009) Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 251:67-76
  32. Kuhn JP, Jahn C, Hernando D et al (2014) T1 bias in chemical shift- encoded liver fat-fraction: role of the flip angle. J Magn Reson Imaging 40:875-883
  33. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB (2007) Fat quantification with IDEAL gradient echo imaging: correction of bias from T1 and noise. Magn Reson Med 58:354-364
  34. Bydder M, Yokoo T, Hamilton G et al (2008) Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 26:347-359
  35. Reeder SB, McKenzie CA, Pineda AR et al (2007) Water-fat sep- aration with IDEAL gradient-echo imaging. J Magn Reson Imaging 25:644-652
  36. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB (2008) Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 60:1122-1134
  37. Hamilton G, Yokoo T, Bydder M et al (2011) In vivo characteriza- tion of the liver fat [1]H MR spectrum. NMR Biomed 24:784-790
  38. Tang A, Tan J, Sun M et al (2013) Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis. Radiology 267:422-431
  39. Patel NS, Doycheva I, Peterson MR et al (2015) Effect of weight loss on MRI estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol 13:561- 565
  40. Publisher's note Springer Nature remains neutral with regard to jurisdic- tional claims in published maps and institutional affiliations.